Skip to content

Clinical trials

Observational Atrial Fibrillation trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Observational Country / region: Singapore Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20132
20164
20181
20191
20201
20211
20221
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Active, not recruiting1
Recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Abbott Medical Devices2
Boehringer Ingelheim2
National Heart Centre Singapore2
Bayer1
Boston Scientific Corporation1
Medtronic Cardiac Ablation Solutions1
National University Hospital, Singapore1
National University of Singapore1
The University of Hong Kong1
Thrombosis Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation14
Stroke3
Arrhythmias, Cardiac1
Cardiac Conduction System Disease1
Cardiovascular Diseases1
Coronary Artery Disease1
Embolism1
Heart Diseases1
Heart Failure1
Neurocognitive Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.